4th International Cancer Conference

4th Crick International Cancer Conference

  • Event date: -
  • Start time: 09:00 End time: - 18:00
  • Event Location: The Francis Crick Institute
  • Event Type: Symposia
The 4th Crick International Cancer Conference will bring together world-leading experts in cancer research and offer many opportunities for in-person networking and engagement.

This conference will highlight recent advancements in our understanding of cancer evolution from tissue homeostasis through to advanced disease and metastasis, with a focus on novel therapeutics. Major themes include:

  • Cancer evolution
  • Cellular regulation
  • Microenvironment and metastasis
  • Targeted and immune therapy

This will be a hybrid event with an in-person audience at the Crick alongside a virtual audience of those who are unable to attend in person.

We are pleased to invite you to submit an abstract for short talks and poster sessions. Abstracts should be submitted by 21st July 2023 using this form.

Early-bird prices are available until Friday 30 June, along with discounted student places.

Confirmed speakers

 Eduard Batlle

Eduard Batlle

IRB Barcelona, Barcelona, Spain

Adrienne A. Boire

Adrienne A. Boire

Memorial Sloan Kettering Cancer Center, New York City, USA

James DeGregori

James DeGregori

University of Colorado Anschutz Medical Campus, Colorado, USA

Trevor Graham

Trevor Graham

The Institute of Cancer Research, London, England
 

Núria López-Bigas

Núria López-Bigas

IRB Barcelona, Barcelona, Spain
 

Yifat Merbl

Yifat Merbl

Weizmann Institute, Rehovot, Israel

Serena Nik-Zainal

Serena Nik-Zainal

CRUK Cambridge Centre, Cambridge, England
 

Daniel Peeper

Daniel Peeper

Netherlands Cancer Institute, Amsterdam, Netherlands

Caetano Reis e Sousa

Caetano Reis e Sousa

The Francis Crick Institute, London, England

Jacco van Rheenen

Jacco van Rheenen

Netherlands Cancer Institute, Amsterdam, Netherlands

Laura Soucek

Laura Soucek

Vall d'Hebron Institute of Oncology, ICREA & Peptomyc S.L

shards

Daniela Thommen

Netherlands Cancer Institute, Amsterdam, Netherlands

Bart Vanhaesebroeck

Bart Vanhaesebroeck

UCL Cancer Institute, London, England
 

shards

Valerie M. Weaver

University of California San Francisco, San Francisco, California


 

Sara Zanivan

Sara Zanivan

CRUK Beatson Institute, Glasgow, Scotland